Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
☕ Buy the dip? After losing 17%, Starbucks sees an estimated 20% upside. See the top Undervalued stocks!Unlock list

Benzinga's Daily Brief On Trending Tickers For April 7, 2022: SDPR S&P 500, Houghton Mifflin, Sunshine Biopharma And More

Published 07/04/2022, 14:43
Updated 07/04/2022, 15:42
© Reuters. Benzinga's Daily Brief On Trending Tickers For April 7, 2022: SDPR S&P 500, Houghton Mifflin, Sunshine Biopharma And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.

The data on the trending tickers is compiled from a list of most-discussed tickers on Benzinga Pro, and the popular Reddit forum WallStreetBets.

SPDR S&P 500 (ARCA: SPY (NYSE:SPY)): The market closed on imbalance on Wednesday, with $279 million on the sell-side, and $1.6 billion on the buy-side as the Fed pointed to a reduction in bond holdings at a maximum of $95 billion per month as the central bank raises interest rates.

Tesla Inc (NASDAQ: TSLA) plans to kick off the Texas Giga factory today with a "Cyber Rodeo" that is expected to attract up to 15,000 people.

Houghton Mifflin Harcourt Co (NASDAQ: HMHC), a learning technology company, completed its sale to private equity investment firm Veritas Capital in a deal valued at $2.8 billion.

Advent Technologies Holdings Inc (NASDAQ: ADN) shares climbed 79.7% to close at $3.63 on Wednesday. Advent and Hyundai Motor Company entered into a technology assessment, sales, and development agreement.

BigBear.ai Holdings Inc (NYSE: BBAI) has moved 28.65% higher in the last five trading sessions on no news as it seems investors have taken interest in BigBear as a momentum play.

Mobiquity Technologies Inc (NASDAQ: MOBQ) surged 29.6% to close at $2.10 after the company announced it has been selected by A-Nation as its data and programmatic advertising provider.

Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares rose 12.1% to close at $6.29. Shares jumped 148% on Tuesday after the company announced two of its designed mRNA molecules are effective at destroying cancer cells grown in culture.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

BioXcel Therapeutics Inc (NASDAQ: BTAI) shares are trading 0.35% higher in Thursday's premarket session. On Wednesday, the stock was trading at a volume of 12.6 million shares as of 1:30 p.m; This is 3642.5% of its average full-day volume over the last 100 days.

Tilray Inc (NASDAQ: TLRY): Analysts at Cantor Fitzgerald maintained a Neutral rating and raised the price target from $6.90 to $8.40 following the company's latest earnings.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.